Events
Company’s insulin-based Imotope™ IMCY-0098 shows excellent safety profile and promising clinical trends
Hutchison China MediTech Limited (“Chi-Med”) shares additional analyses from three completed and ongoing clinical studies of fruquintinib and savolitinib at the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (“CSCO”) on September 18 to 22, 2019 in Xiamen, China.
Dornier MedTech Launches New Image Post-Processing Software for Urology to Improve Kidney Stone Treatment Outcomes
MorphoSys AG will present at the following conferences
Simplify Medical Pty Ltd. announced that data from three sites in the Company’s single-level Investigational Device Exemption (IDE) clinical trial evaluating the Simplify® Disc for total cervical disc replacement was selected as a Podium Presentation during the 2019 North American Spine Society (NASS) Annual Meeting, being held September 25-28 in Chicago, IL.
The Award recognizes Patient Entrepreneurs demonstrating outstanding innovations which advance solutions in the prevention, management or care of cancer
Eisai Co., Ltd. has announced that it received the 33rd “IIA Japan Chairman’s Award” of the Institute of Internal Auditors
Santhera Pharmaceuticals will present data on the therapeutic effects of long-term treatment with Puldysa® in Duchenne muscular dystrophy at the forthcoming medical conferences of the European Paediatric Neurology Society, European Respiratory Society and World Muscle Society.
Oncoceutics, a clinical-stage drug discovery and development company, commemorates National Childhood Cancer Awareness Month this September and reiterates its support for children and all those affected by childhood cancer.
Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc., presented data from the Phase 1 clinical trial of AKCEA-TTR-LRx in a poster presentation at the Heart Failure Society of America 23rd Annual Scientific Meeting in Philadelphia, Pennsylvania.
PRESS RELEASES